SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-15-000811
Filing Date
2015-03-12
Accepted
2015-03-12 16:03:06
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 849911
2 logo.jpg GRAPHIC 8693
3 ex3-1.htm EX-3.1 17595
4 ex21-1.htm EX-21.1 2575
5 ex23-1.htm EX-23.1 3937
6 ex31-1.htm EX-31.1 15805
7 ex31-2.htm EX-31.2 16839
8 ex32-1.htm EX-32.1 7493
  Complete submission text file 0001493152-15-000811.txt   8080667

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE immy-20141231.xml EX-101.INS 998481
10 XBRL SCHEMA FILE immy-20141231.xsd EX-101.SCH 76007
11 XBRL CALCULATION FILE immy-20141231_cal.xml EX-101.CAL 95667
12 XBRL DEFINITION FILE immy-20141231_def.xml EX-101.DEF 265827
13 XBRL LABEL FILE immy-20141231_lab.xml EX-101.LAB 536520
14 XBRL PRESENTATION FILE immy-20141231_pre.xml EX-101.PRE 397514
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 15695920
SIC: 2834 Pharmaceutical Preparations